Ultragenyx
Price & Volume
Stats
See more52W Range | $25.81-$57.99 |
Market Cap | $3B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $610.1M |
Revenue Growth (YoY) | 13.2% |
Gross Profit (12 Mos) | -$167.8M |
Diluted EPS | -$5.48 |
News
See moreYahoo Finance • 5 days ago
Ultragenyx annuncia l'approvazione da parte dell'AIFA (Agenzia Italiana del Farmaco) del rimborso di Evkeeza® (evinacumab) per i pazienti pediatrici di età pari a 6 mesi con ipercolesterolemia familiare omozigote (HoFH)
Yahoo Finance • 9 days ago
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 11 days ago
Assenagon Boosts Ultragenyx Pharmaceutical Inc. (RARE) Stake by 439% Amid Breakthrough Pipeline
Yahoo Finance • 12 days ago
Ultragenyx Appoints Eric Olson as Chief Business Officer and Executive Vice President
About
CEO | Dr. Emil D. Kakkis M.D., Ph.D. |
CFO | Mr. Howard Horn |
Address | 60 Leveroni Court, Novato, CA, United States, 94949 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,294 |
